JLPC's subsidiaries sign strategic cooperation agreements
On September 10th, Chengdu Yazhong Biopharmaceutical Co., Ltd. signed a deep strategic cooperation agreement with Yangzhou Lianhuan Investment Co., Ltd. and Nanjing Lianzhi Pharmaceutical Technology Co., Ltd. As subsidiaries of Lianhuan Pharmaceutical, Yazhong Pharmaceutical, Lianhuan Investment, and Nanjing Lianzhi will jointly establish a project team to fully promote the early market launch and transformation of research and development varieties; at the same time, through the deep integration of the upstream and downstream of the industrial chain, further enhance Lianhuan Pharmaceutical's core competitiveness in the field of cardiovascular treatment
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments